Quick Takeaways
- AltraVue Capital, LLC filed SCHEDULE 13G/A for Avid Bioservices, Inc. Common (CDMO).
- Disclosed ownership: 5.9%.
- Date of event: 31 Dec 2024.
AltraVue Capital, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Avid Bioservices, Inc. Common (CDMO)
- Filing Manager
- AltraVue Capital, LLC
- Reporting Manager
- AltraVue Capital, LLC
- Security
- Avid Bioservices, Inc. Common
- Symbol
- CDMO
- Shares outstanding
- 64,369,712 shares
- Disclosed Ownership
- 3,797,813 shares
- Ownership
- 5.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Jan 2025, 13:49:56 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"AltraVue Capital, LLC disclosed 5.9% ownership in Avid Bioservices, Inc. Common (CDMO) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Jan 2025, 13:49.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AltraVue Capital, LLC | 5.9% | 3,797,813 | 2,337,088 | 1,460,725 | Tom Parkhurst | Chief Compliance Officer |